Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Short term Debt: 2022-2023

  • Orchestra BioMed Holdings' Short term Debt was N/A to $9.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.6 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2022, which is N/A change from last year.
  • Orchestra BioMed Holdings' Short term Debt amounted to $9.6 million in Q3 2023, which was up 359.50% from $2.1 million recorded in Q4 2022.
  • Over the past 5 years, Orchestra BioMed Holdings' Short term Debt peaked at $9.6 million during Q3 2023, and registered a low of $2.1 million during Q4 2022.
  • Its 2-year average for Short term Debt is $5.8 million, with a median of $5.8 million in 2022.